Biophytis SA (BPTSY)
8.02
-1.40
(-14.86%)
USD |
OTCM |
May 10, 16:00
Biophytis Shareholders Equity (Quarterly): -4.264M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.264M |
| June 30, 2023 | -3.610M |
| June 30, 2023 | -3.610M |
| December 31, 2022 | -2.015M |
| June 30, 2022 | 3.126M |
| June 30, 2022 | 3.126M |
| December 31, 2021 | 6.606M |
| June 30, 2021 | 7.141M |
| June 30, 2021 | 7.141M |
| December 31, 2020 | 2.828M |
| June 30, 2020 | -4.955M |
| Date | Value |
|---|---|
| June 30, 2019 | -2.957M |
| March 31, 2019 | 2.711M |
| June 30, 2018 | 18.13M |
| June 30, 2018 | 18.13M |
| December 31, 2017 | 25.46M |
| June 30, 2017 | 8.040M |
| June 30, 2017 | 8.040M |
| December 31, 2016 | 4.809M |
| June 30, 2016 | 9.217M |
| June 30, 2016 | 9.217M |
| December 31, 2015 | 12.71M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-4.955M
Minimum
Jun 2020
7.141M
Maximum
Jun 2021
0.7132M
Average
0.4063M
Median
Shareholders Equity (Quarterly) Benchmarks
| Edap TMS SA | 62.92M |
| DBV Technologies SA | 140.19M |
| Cellectis SA | 84.70M |
| Genfit SA | 75.11M |
| Adaptimmune Therapeutics PLC | 39.51M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.22M |
| Total Liabilities (Quarterly) | 17.52M |